HAMMOND JANET MJ

PrivateCIK: 1829899

HAMMOND JANET MJ (Chief Development Officer) exercised options at ATEA PHARMACEUTICALS, INC.

Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.

M · 1 exercise
InsiderHAMMOND JANET MJCIK 1829899
Officer· Chief Development Officer
Since Oct 2020
+162.86K
Net shares
Net buyer
$59.9K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
235.05K acquired · 72.19K disposed
Non-Derivative Transactions2

Common Stock

Direct
M · Option Exercise

Shares

+58.05K

Price / share

Trade value

% of position

69.3%
1/31/2026
83.75K141.80K

Common Stock

Direct
F · Tax Withholding

Shares

14.14K

Price / share

$4.24

Trade value

$59.94K

% of position

10.0%
1/31/2026
141.80K127.67K
Total

Net shares

+43.91K

Net value

-$59.94K

Derivative Transactions3

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

46.80K shares

Shares

46.80K

Strike price

Held after

0.00

Exercisable

1/31/2026

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

11.25K shares

Shares

11.25K

Strike price

Held after

0.00

Exercisable

1/31/2026

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

177K shares

Shares

+177K

Strike price

4.24

Held after

177K

Exercisable

1/31/2026
HAMMOND JANET MJ — Insider Transaction (Form 4) Filed Feb 3, 2026 | Finecho